
|Videos|July 27, 2021
Dr. Helfand on the increasing role of genomic testing in prostate cancer
Author(s)Urology Times staff
Advertisement
Brian T. Helfand, MD, PhD, NorthShore University HealthSystem, explains the increased significance of genomic testing in the field of prostate cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Ac-225 rosopatamab tetraxetan shows promising activity in Lu-PSMA–pretreated mCRPC
2
FDA updates in urology: June 2026
3
Gopa Iyer, MD, highlights data on anti-Nectin-4 ADC for metastatic urothelial carcinoma
4
Economic analysis: SURE reduces downstream stone costs
5












